Solvotrin Therapeutics

Solvotrin Therapeutics

Solvotrin Therapeutics

Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs.
Type
B2b
Founded
2009
Raised
$9.9M
Follow us
Alexa global traffic share
Latest funding
€6,700,000
Venture capital - 2020
Elkstone RAB Capital
€2,000,000
Venture capital - 2017
Kevin Fielding Elkstone Capital Partners
Team Size
10+
Employees
Location
Headquarters
€6,700,000 Venture capital
SiliconRepublic

Cork-based healthcare company raises €6.7m in funding

€2,000,000 Venture capital
Independent.ie

Venture capitalist Fielding helps pharma company Solvotrin raise €2m